Emergent BioSolutions Inc. (NYSE:EBS) today announced the anticipated executive management team of Aptevo Therapeutics Inc., Emergent’s planned Biosciences business spin-off company. Members of the Aptevo executive management team will be appointed to their positions effective upon completion of the tax-free spin-off of Aptevo, expected to occur in mid-2016.
“We are pleased to have such an experienced and talented group of individuals to lead Aptevo Therapeutics,” said Daniel J. Abdun-Nabi, president and chief executive officer of Emergent BioSolutions. “These individuals possess the expertise, commitment, and passion to build on the successes of Emergent’s biosciences business for it to grow as a stand-alone publicly-traded company.”
{iframe}http://www.econotimes.com/Emergent-BioSolutions-Announces-Executive-Management-Team-of-New-Spin-Off-Company-Aptevo-Therapeutics-147239{/iframe}